Skip to main content Skip to footer
Dyne Medical Central Publications
Scientific Congresses Journal Articles
Home Scientific Congresses Journal Articles

2025 Congresses

Back

The FORCE™ platform, zeleciment-basivarsen (z-basivarsen, also known as DYNE-101), zeleciment-rostudirsen (z-rostudirsen, also known as DYNE-251), DYNE-302, and DYNE-401 are investigational or otherwise in development and have not been approved as safe or effective by the US FDA, EMA or any other regulatory authority.

American Academy of Neurology 2025 (AAN)

View content

European Paediatric Neurology Society Congress 2025 (EPNS)

View content

International Research Congress on FSHD 2025

View content

Muscular Dystrophy Association Conference 2025 (MDA)

View content

Neuromuscular Study Group Annual Scientific Meeting 2025 (NMSG)

View content

Ottawa International Conference on Neuromuscular Disease and Biology 2025 (Ottawa NMD)

View content

UK Neuromuscular Translational Research Conference 2025 (NTRC)

View content

World Muscle Society Congress 2025 (WMS)

View content

WORLDSymposium 2025

View content
Privacy Policy

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.

Dyne Medical Central

Privacy controls

Cookie settings

This build uses essential first-party storage for HCP verification and preferences. Optional analytics remain off until an approved consent integration is configured.

Video player

Open video in a new tab

YOU ARE NOW LEAVING THE DYNE MEDICAL CENTRAL WEBSITE.

Dyne Therapeutics, Inc. supports accredited continuing education (CE) for healthcare professionals across therapeutic areas of interest. These CE activities are planned, developed and delivered by independent accredited providers in accordance with the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education, or the standards of other similar accrediting organizations. Dyne Therapeutics, Inc. does not exercise control over, or provide guidance to, any accredited provider. Dyne Therapeutics, Inc. is sharing CE information on this page as a service to the medical community and with permission from the accredited providers. The information on this page is intended to provide self-service to educational topics of interest, and most activities are free to the learner (some may require a nominal registration fee per the accredited provider's requirements).

CONTINUE